Can we conquer pain?

Nature Neuroscience

Volumn 5, Issue 11s, 2002, Pages 1062-1067

  Scholz, Joachim ^a   Woolf, Clifford J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTICONVULSIVE AGENT; CARBAMAZEPINE; COCAINE; CODEINE; CYCLOOXYGENASE 2 INHIBITOR; DEXTROMETHORPHAN; GABAPENTIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; SALICYLIC ACID; SEROTONIN 1B AGONIST; SEROTONIN 1D AGONIST; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT;

CENTRAL NERVOUS SYSTEM; HUMAN; HYPERSENSITIVITY; PAIN; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; REVIEW; SENSATION; STOMACH HEMORRHAGE; TISSUE REPAIR;

AFFERENT PATHWAYS; ANALGESICS; ANIMALS; CENTRAL NERVOUS SYSTEM; DRUG DESIGN; HUMANS; NOCICEPTORS; PAIN; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION;

EID: 0036829011     PISSN: 10976256     EISSN: 15461726     Source Type: Journal    
DOI: 10.1038/nn942     Document Type: Review

References (24)

1. Julius, D. & Basbaum, A. I. Molecular mechanisms of nociception. Nature 413, 203-210 (2001).
2. Woolf, C. J. & Salter, M. W. Neuronal plasticity—increasing the gain in pain. Science 288, 1765-1768 (2000).
3. Sindrup, S. H. & Jensen, T. S. Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain 83, 389-400 (1999).
4. Lynch, D. in Practical Management of Pain 3rd edn. (ed. Raj, P.P.) 270-293 (Mosby, St. Louis, Missouri, 2000).
5. Woolf, C. J. & Mannion, R. J. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 353, 1959-1964 (1999).
6. Porreca, F., Ossipov, M. H. & Gebhart, G. F. Chronic pain and medullary descending facilitation. Trends Neuro sci. 25, 319-325 (2002).
7. Boddeke, E. W. Involvement of chemokines in pain. Eur. J. Pharmacol. 429, 115-119 (2001).
8. Mantyh, P. W., Clohisy, D. R., Koltzenburg, M. & Hunt, S. P. Molecular mechanisms of cancer pain. Nature Rev.Cancer 2, 201-209 (2002).
9. Fields, H. L. Pain modulation: expectation, opioid analgesia and virtual pain. Prog. Brain Res. 122, 245-253 (2000).
10. Woolf, C. J. & Max, M. B. Mechanism-based pain diagnosis: issues for analgesic drug development. Anesthesiol. 95, 241-249 (2001).
11. Hunt, S. P. & Mantyh, P. W. The molecular dynamics of pain control. Nat. Rev. Neurosci. 2, 83-91 (2001).
12. Svensson, C. I. & Yaksh, T. L. The spinal phospholipase-cyclooxygenase-prostanoid cascade in nociceptive processing. Annu. Rev. Pharmacol. Toxicol. 42, 553-583 (2002).
13. Burstein, R., Yarnitsky, D., Goor-Aryeh, I., Ransil, B. J. & Bajwa, Z. H. An association between migraine and cutaneous allodynia. Ann. Neurol. 47, 614-624 (2000).
14. Sarkar, S., Aziz, Q., Woolf, C. J., Hobson, A. R. & Thompson, D. G. Contribution of central sensitisation to the development of non-cardiac chest pain. Lancet 356, 1154-1159 (2000).
15. Watkins, L. R., Milligan, E. D. & Maier, S. F. Glial activation: a driving force for pathological pain. Trends Neurosci. 24, 450-455 (2001).
16. Rittner, H. L. et al. Opioid peptide-expressing leukocytes: identification, recruitment, and simultaneously increasing inhibition of inflammatory pain. Anesthesiology 95, 500-508 (2001).
17. Rose, M. A. & Kam, P. C. Gabapentin: pharmacology and its use in pain management. Anaesthesia 57, 451-462 (2002).
18. Goadsby, P. J., Lipton, R. B. & Ferrari, M. D. Migraine—current understanding and treatment. N. Engl. J. Med. 346, 257-270 (2002).
19. FitzGerald, G. A. & Patrono, C. The coxibs, selective inhibitors of cyclooxygenase-2. N. Engl. J. Med. 345, 433-442 (2001).
20. Flores, C. M. & Mogil, J. S. The pharmacogenetics of analgesia: toward a genetically-based approach to pain management. Pharmacogenomics 2, 177-194 (2001).
21. Desmeules, J. A., Oestreicher, M. K., Piguet, V., Allaz, A. F. & Dayer, P. Contribution of cytochrome P-4502D6 phenotype to the neuromodulatory effects of dextromethorphan. J. Pharmacol. Exp. Ther. 288, 607-612 (1999).
22. Wood, J. N. II. Genetic approaches to pain therapy. Am. J. Physiol. Gastrointest. Liver Physiol. 278, G507-G512 (2000).
23. Mogil, J. S. The genetic mediation of individual differences in sensitivity to pain and its inhibition. Proc. Natl. Acad. Sci. USA 96, 7744-7751 (1999).
24. Becerra, L., Breiter, H. C., Wise, R., Gonzalez, R. G. & Borsook, D. Reward circuitry activation by noxious thermal stimuli. Neuron 32, 927-946 (2001).